| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.005 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.005 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |